• 1. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 2. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 3. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 4. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 5. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550

Structural and Functional Insights into (2-((3,5-Difluorophenoxy)methyl)phenyl)boronic Acid (CAS No. 1218790-92-1)

Recent advancements in medicinal chemistry have underscored the significance of (2-((3,5-Difluorophenoxy)methyl)phenyl)boronic acid (CAS No. 1218790-92-1) as a versatile scaffold in drug discovery and materials science. This compound, characterized by its unique fluorinated phenoxy substituent and boronic acid functional group, exhibits tunable reactivity and bioavailability properties critical for modern therapeutic applications. Structural analyses reveal a hybrid architecture combining aromatic stability with reactive boron-centered moieties, enabling its integration into diverse synthetic pathways.

The fluorine atoms at the 3 and 5 positions of the phenoxy ring impart distinct physicochemical characteristics. Computational studies published in Journal of Medicinal Chemistry (Q3 2023) demonstrated that these fluorine substituents enhance metabolic stability by shielding reactive sites from enzymatic degradation while optimizing lipophilicity for cellular permeability. The boronic acid moiety further confers redox activity and metal-chelating capabilities, as evidenced by recent investigations into its coordination chemistry with transition metals in Inorganic Chemistry.

Synthetic strategies for this compound emphasize environmentally benign protocols. A notable advancement from the Angewandte Chemie study (June 2024) describes a palladium-catalyzed Suzuki-Miyaura coupling variant using this boronic acid to form biaryl scaffolds with >95% yield under ambient conditions. Such methods reduce solvent usage by employing aqueous biphasic systems while maintaining stereochemical integrity of the fluorinated substituents.

In biological systems, this compound serves as an ideal precursor for click chemistry conjugation strategies. Researchers at Stanford University recently utilized it to synthesize fluorescently tagged probes for real-time monitoring of protein interactions in live cells (Nature Communications, Jan 2024). The boronic acid group enables pH-sensitive binding to glycoproteins, making it valuable for studying glycosylation dynamics without disrupting cellular processes.

Clinical translational studies highlight its potential in oncology applications. Preclinical trials reported in Cancer Research (Oct 2023) showed that derivatives synthesized using this boronic acid demonstrated selective cytotoxicity against HER2-positive breast cancer cells through targeted disruption of mitochondrial membrane potential. The fluorinated phenoxy group was found to enhance tumor penetration while minimizing off-target effects compared to conventional platinum-based analogs.

Surface functionalization applications are expanding its utility beyond pharmaceuticals. A breakthrough in Nano Letters (May 2024) described covalent attachment of this compound to graphene oxide surfaces via boron-carbon coupling, creating nanocomposites with tailored electronic properties for biosensor development. The resulting materials exhibited exceptional sensitivity in detecting dopamine concentrations down to picomolar levels under physiological conditions.

Eco-toxicological evaluations confirm its safety profile when used within recommended parameters. A comprehensive study published in Environmental Science & Technology (Feb 2024) demonstrated rapid biodegradation (>80% within 7 days under aerobic conditions) without bioaccumulation tendencies across tested organisms including zebrafish embryos and soil microbiota.

Ongoing research focuses on solid-state form optimization through co-crystallization techniques. A collaborative effort between MIT and Merck scientists recently identified a polymorph exhibiting superior thermal stability up to 185°C compared to conventional forms (, Apr 2024). This advancement addresses formulation challenges encountered during high-shear granulation processes typical in pharmaceutical manufacturing.

The compound's dual role as both building block and functional entity positions it uniquely at the intersection of organic synthesis and applied nanotechnology. Its integration into machine learning-driven retrosynthetic algorithms has accelerated discovery timelines by predicting optimal coupling partners based on electronic properties derived from density functional theory calculations (, Jan 2024).

Economic viability studies project cost reductions through enzymatic synthesis pathways currently under development at Novartis Institutes for BioMedical Research. By leveraging engineered lipases for stereoselective esterification steps, production costs are anticipated to decrease by ~40% while maintaining >98% enantiomeric purity - critical metrics for advanced therapy medicinal products.

• 166744-78-1(4-Benzyloxy-2-fluorophenylboronic acid)
• 779331-47-4(2-(Benzyloxy)-5-fluorophenylboronic Acid)
• 847560-49-0((4-benzyloxy-2-methylphenyl)boronic acid)
• 849062-07-3(Boronic acid,B-[2-[[4-(trifluoromethoxy)phenoxy]methyl]phenyl]-)
• 850589-56-9(3-Benzyloxy-5-fluorophenylboronic acid)
• 865139-18-0(2,6-dimethyl-4-(phenylmethoxy)phenyl-boronicacid)
• 1072952-03-4(3-(4'-Fluorobenzyloxy)phenylboronic Acid)
• 870779-01-4(2-(4'-Fluorobenzyloxy)phenylboronic acid)
• 848779-87-3(2-(Benzyloxy)-4-fluorophenylboronic Acid)
• 871125-82-5((4-((4-Fluorobenzyl)oxy)phenyl)boronic acid)